Company profile
Newleos Therapeutics
Newleos is working to develop safer and more effective treatment options for major mental health conditions.
- Industry
- Biotechnology Research
- Employees
- 29
- Headquarters
- Boston, Massachusetts
- Founded
- 2024
- LinkedIn followers
- 3,664
- Office locations
- 1
Newleos Therapeutics company summary
Newleos Therapeutics is a company in the Biotechnology Research industry, headquartered in Boston, Massachusetts, founded in 2024. On LinkedIn the company has around 29 employees and 3,664 followers.
What technology does Newleos Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Newleos Therapeutics
We are dedicated to providing a new dawn or "eos" for patients with mental health conditions by developing next generation, first- and best-in-class therapies. Over 100 million patients in the United States are affected by neuropsychiatric disorders, with anxiety and substance use disorders among the largest areas of unmet medical need. Our clinical-stage pipeline was licensed from Roche and includes oral small molecules targeting GABAA-γ1, V1a, TAAR1 and GABAA-α5 with broad potential in general anxiety, social anxiety, substance use disorders and cognitive impairment. Newleos was co-founded by Longwood Fund, Federico Bolognani, M.D., Ph.D., and William Martin, Ph.D., seasoned experts in company creation and CNS drug development.
Where is Newleos Therapeutics located?
Newleos Therapeutics lists 1 location.
Compare companies similar to Newleos Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Newleos Therapeutics newleos.com | Biotechnology Research | 29 | 2024 | Boston, Massachusetts |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Newleos Therapeutics
What does Newleos Therapeutics do?
We are dedicated to providing a new dawn or "eos" for patients with mental health conditions by developing next generation, first- and best-in-class therapies. Over 100 million patients in the United States are affected by neuropsychiatric disorders, with anxiety and substance use disorders among the largest areas of unmet medical need. Our clinical-stage pipeline was licensed from Roche and includes oral small molecules targeting GABAA-γ1, V1a, TAAR1 and GABAA-α5 with broad potential in general anxiety, social anxiety, substance use disorders and cognitive impairment. Newleos was co-founded by Longwood Fund, Federico Bolognani, M.D., Ph.D., and William Martin, Ph.D., seasoned experts in company creation and CNS drug development.
How many employees does Newleos Therapeutics have?
Newleos Therapeutics has around 29 employees on LinkedIn.
Where is Newleos Therapeutics headquartered?
Newleos Therapeutics is headquartered in Boston, Massachusetts.
When was Newleos Therapeutics founded?
Newleos Therapeutics was founded in 2024.
Build a lead list from companies like Newleos Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.